Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Low Serum Levels of DKK2 Predict Incident Low-Impact Fracture in Older Women.

Rodrigues AM, Eusébio M, Rodrigues AB, Caetano-Lopes J, Lopes IP, Lopes A, Mendes JM, Coelho PS, Fonseca JE, Branco JC, Canhão H.

JBMR Plus. 2019 Mar 28;3(7):e10179. doi: 10.1002/jbm4.10179. eCollection 2019 Jul.

2.

Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.

Carrillo-López N, Panizo S, Alonso-Montes C, Román-García P, Rodríguez I, Martínez-Salgado C, Dusso AS, Naves M, Cannata-Andía JB.

Kidney Int. 2016 Jul;90(1):77-89. doi: 10.1016/j.kint.2016.01.024. Epub 2016 Mar 24.

PMID:
27165819
3.

Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Roforth MM, Fujita K, McGregor UI, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG, Khosla S.

Bone. 2014 Feb;59:1-6. doi: 10.1016/j.bone.2013.10.019. Epub 2013 Oct 29.

4.

Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.

García-Ibarbia C, Delgado-Calle J, Casafont I, Velasco J, Arozamena J, Pérez-Núñez MI, Alonso MA, Berciano MT, Ortiz F, Pérez-Castrillón JL, Fernández AF, Fraga MF, Zarrabeitia MT, Riancho JA.

Gene. 2013 Dec 15;532(2):165-72. doi: 10.1016/j.gene.2013.09.080. Epub 2013 Oct 2.

PMID:
24096177
5.

A pilot trial on the molecular pathophysiology of traumatic temporomandibular joint bony ankylosis in a sheep model. Part I: Expression of Wnt signaling.

Yan YB, Li JM, Xiao E, An JG, Gan YH, Zhang Y.

J Craniomaxillofac Surg. 2014 Mar;42(2):e15-22. doi: 10.1016/j.jcms.2013.04.009. Epub 2013 May 24.

PMID:
23707780
6.

Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.

Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II.

Osteoporos Int. 2013 Aug;24(8):2191-9. doi: 10.1007/s00198-013-2268-y. Epub 2013 Jan 29.

PMID:
23358608
7.

Microarray expression analysis of genes and pathways involved in growth plate cartilage injury responses and bony repair.

Macsai CE, Georgiou KR, Foster BK, Zannettino AC, Xian CJ.

Bone. 2012 May;50(5):1081-91. doi: 10.1016/j.bone.2012.02.013. Epub 2012 Feb 22.

PMID:
22387305
8.

Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts.

Boudin E, Piters E, Fransen E, Nielsen TL, Andersen M, Roef G, Taes Y, Brixen K, Van Hul W.

Mol Genet Metab. 2012 Mar;105(3):508-15. doi: 10.1016/j.ymgme.2011.11.189. Epub 2011 Nov 23.

PMID:
22178351
9.

Wnt signaling as a therapeutic target for bone diseases.

Hoeppner LH, Secreto FJ, Westendorf JJ.

Expert Opin Ther Targets. 2009 Apr;13(4):485-96. doi: 10.1517/14728220902841961 . Review.

10.

Secreted frizzled related protein 1 is a target to improve fracture healing.

Gaur T, Wixted JJ, Hussain S, O'Connell SL, Morgan EF, Ayers DC, Komm BS, Bodine PV, Stein GS, Lian JB.

J Cell Physiol. 2009 Jul;220(1):174-81. doi: 10.1002/jcp.21747.

11.

Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development.

Trevant B, Gaur T, Hussain S, Symons J, Komm BS, Bodine PV, Stein GS, Lian JB.

J Cell Physiol. 2008 Oct;217(1):113-26. doi: 10.1002/jcp.21482.

12.

Wnt signaling and osteoblastogenesis.

Bodine PV, Komm BS.

Rev Endocr Metab Disord. 2006 Jun;7(1-2):33-9. Review.

PMID:
16960757

Supplemental Content

Loading ...
Support Center